KOCAA
HRTX icon

Knights of Columbus Asset Advisors’s Heron Therapeutics HRTX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41,741
Closed -$146K – 422
2024
Q2 		$146K Hold
41,741
– – 0.01% 349
2024
Q1 		$116K Sell
41,741
-41,741
-50% -$105K 0.01% 336
2023
Q4 		$142K Buy
83,482
+41,741
+100% +$46K 0.01% 332
2023
Q3 		$43K Hold
41,741
– – ﹤0.01% 362
2023
Q2 		$48.4K Hold
41,741
– – ﹤0.01% 362
2023
Q1 		$63K Hold
41,741
– – 0.01% 346
2022
Q4 		$104K Hold
41,741
– – 0.01% 315
2022
Q3 		$176K Hold
41,741
– – 0.02% 284
2022
Q2 		$116K Sell
41,741
-42,384
-50% -$170K 0.01% 295
2022
Q1 		$481K Buy
84,125
+969
+1% +$7.09K 0.04% 250
2021
Q4 		$759K Buy
83,156
+1,407
+2% +$14.4K 0.06% 234
2021
Q3 		$874K Buy
81,749
+500
+0.6% +$6.09K 0.08% 230
2021
Q2 		$1.26M Buy
81,249
+630
+0.8% +$10K 0.12% 222
2021
Q1 		$1.31M Buy
80,619
+22,662
+39% +$404K 0.13% 234
2020
Q4 		$1.23M Sell
57,957
-410
-0.7% -$7.13K 0.13% 240
2020
Q3 		$865K Sell
58,367
-8,316
-12% -$130K 0.11% 244
2020
Q2 		$981K Sell
66,683
-1,238
-2% -$20.3K 0.12% 251
2020
Q1 		$797K Sell
67,921
-6,759
-9% -$127K 0.1% 274
2019
Q4 		$1.75M Buy
+74,680
New +$1.65M 0.15% 235

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knights of Columbus Asset Advisors's HRTX Position: Q3 2024 in Review

Knights of Columbus Asset Advisors sold out of Heron Therapeutics (HRTX) in Q3 2024, closing a stake of 41,741 shares — an estimated $146K sold.

Knights of Columbus Asset Advisors first reported a position in HRTX in Q4 2019 and held it in 19 quarters. The position peaked at $1.75M in Q4 2019. 173 funds tracked by Wall St. Rank hold HRTX as of Q3 2024.

  • Knights of Columbus Asset Advisors reported no remaining Heron Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 41,741 Heron Therapeutics shares in Q3 2024, an estimated $146K.
  • Knights of Columbus Asset Advisors first reported a position in Heron Therapeutics in Q4 2019 and held it in 19 quarters.
  • Knights of Columbus Asset Advisors's Heron Therapeutics position peaked at $1.75M in Q4 2019.
  • 173 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.